Wednesday Nov 11 | South End Standard
Drug for cancer is easier to find
A HEALTHCARE assistant was spurred into action to improve the supply of cancer fighting drugs after a breast cancer patient was unable to get her prescription.
ASCO Expert Corner: Hormone Therapy Options for Early-Stage Breast Cancer
Hormone therapy is a treatment option for women with early-stage, hormone-sensitive breast cancer, identified by the presence of hormone receptors.
Results In 'The New England Journal Of Medicine' Confirm Novartis...
Main Category: Breast Cancer Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 20 Aug 2009 - 2:00 PDT Newly published data in The New England Journal of Medicine affirm five-year upfront use of Femara ) following surgery as an optimal treatment approach versus tamoxifen for postmenopausal women with ...
Femara Increases Survival after Breast Cancer Surgery More Then Tamoxifen
For postmenopausal women with breast cancer, treatment with the drug letrozole increases survival after surgery more than the widely used tamoxifen, a new study confirms.
Newer Drug Beats Tamoxifen for Older Breast Cancer Patients
For postmenopausal women with breast cancer, treatment with the drug letrozole increases survival after surgery more than the widely used tamoxifen, a new study confirms.
The combination of two drugs-- Femara and follicle-stimulating hormone --could be of benefit in infertile women of advanced reproductive age undergoing intrauterine insemination, results of a study indicate.
Fertility drug combo promising in older women
The combination of two drugs -- Femara and follicle-stimulating hormone -- could be of benefit in infertile women of advanced reproductive age undergoing intrauterine insemination, results of a study indicate.
FDA gives tentative approval to generic breast cancer treatment
ROCKVILLE,A Md. The Food and Drug Administration has given tentative approval to a generic drug for treating breast cancer.
Data on more than 15 Novartis Oncology compounds at ASCO highlight...
The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- * Oral presentation on Sandostatin LAR Phase III data shows significant antitumor benefit in patients with advanced neuroendocrine tumors of the midgut * Early data show that at eight weeks of ...
Infertility Treatment - Get 'Femara' Way, and Get a Better Chance of Ovulating
There are several infertility treatment methods that people can opt when the should face the miserable truth that they are affected by infertility.
Also on Topix